| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/14/2011 | US20110172210 Method for titrating clozapine |
| 07/14/2011 | US20110172209 3h-imidazo[4,5-b]pyridin-5-ol derivatives useful in the treatment of gpr81 receptor disorders |
| 07/14/2011 | US20110172208 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition |
| 07/14/2011 | US20110172207 Substituted pyrazolamides and their use |
| 07/14/2011 | US20110172206 Compositions and methods for treatment of neurodegenerative disease |
| 07/14/2011 | US20110172205 Monocyclic amide cgrp receptor antagonists |
| 07/14/2011 | US20110172204 Compounds and their use |
| 07/14/2011 | US20110172203 Substituted Imidazopyridinyl-Aminopyridine Compounds |
| 07/14/2011 | US20110172202 Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis |
| 07/14/2011 | US20110172201 Process for preparing a carbapenem antibiotic composition |
| 07/14/2011 | US20110172200 Use of inhibitor of beta-lactamases and its combination with beta-lactam antibiotics |
| 07/14/2011 | US20110172199 Platinum-n-heterocyclic carbene derivatives, preparation thereof and therapeutic use thereof |
| 07/14/2011 | US20110172198 TGR5 Modulators And Methods Of Use Thereof |
| 07/14/2011 | US20110172197 Dosace Form For Hormonal Contraceptive |
| 07/14/2011 | US20110172196 Pharmaceutical composition and method for treating hypogonadism |
| 07/14/2011 | US20110172195 Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance |
| 07/14/2011 | US20110172194 Composition of dialysis liquid comprising crystallisation inhibitor substances |
| 07/14/2011 | US20110172193 Pro-drugs of (e)-7-(3-(2-amino-1-fluoroethylidene)piperidin-1-yl)-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| 07/14/2011 | US20110172192 Method and compositions for treating hematological malignancies |
| 07/14/2011 | US20110172191 Thieno-pyridine derivatives as mek inhibitors |
| 07/14/2011 | US20110172190 Agents for preventing and treating disorders involving modulation of the ryanodine receptors |
| 07/14/2011 | US20110172189 Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use |
| 07/14/2011 | US20110172188 Use of anti-connexin agents for modulating the therapeutic effect of psychotropic drugs |
| 07/14/2011 | US20110172187 Boron-containing small molecules |
| 07/14/2011 | US20110172186 Inhibitors of fatty acid amide hydrolase |
| 07/14/2011 | US20110172185 Therapeutic drug for adult t-cell leukemia |
| 07/14/2011 | US20110172184 Antitumor agent containing 4 - [[3,5 - bis (trimethylsilyl) benzoyl] amino] benzoic acid |
| 07/14/2011 | US20110172182 Carboxyethylated Cyclodextrin Polysulfates Useful As Medicaments |
| 07/14/2011 | US20110172181 Compositions and Methods of Aloe Polysaccharides |
| 07/14/2011 | US20110172179 Micronutrient formulations for radiation applications |
| 07/14/2011 | US20110172178 Beta-l-2' deoxynucleosides for the treatment of resistant hbv strains and combination therapies |
| 07/14/2011 | US20110172177 Combination, kit and method of reducing intraocular pressure |
| 07/14/2011 | US20110172176 Crystal structures of sglt2 inhibitors and processes for preparing same |
| 07/14/2011 | US20110172174 Antibacterial agents |
| 07/14/2011 | US20110172172 Method of Treating Neurological Conditions with Cardiac Glycoside |
| 07/14/2011 | US20110172171 Taurine or taurine-like substances for the prevention of brain oedema |
| 07/14/2011 | US20110172169 Method of Detection of Nucleic Acids with a Specific Sequence Composition |
| 07/14/2011 | US20110172162 Chemotherapy involving antisense oligonucleotides for preventing and/or treating pulmonary fibrosis |
| 07/14/2011 | US20110172156 Methods and compositions for treating bleeding disorders |
| 07/14/2011 | US20110172149 Method of Regulating Glucose Metabolism, and Reagents Related Thereto |
| 07/14/2011 | US20110172144 Methods for increasing expression of serca2a in cardiac muscle |
| 07/14/2011 | US20110172141 Process for preparing microparticles |
| 07/14/2011 | US20110171727 Compositions and methods for activating genes of interest |
| 07/14/2011 | US20110171328 Pharmaceutical composition for treating diabetes |
| 07/14/2011 | US20110171325 Systems and Methods for Treating Pain Using Brain Stimulation |
| 07/14/2011 | US20110171323 Methods and kits to predict prognostic and therapeutic outcome in small cell lung cancer |
| 07/14/2011 | US20110171320 Methods to extend vision to infrared wavelengths |
| 07/14/2011 | US20110171319 Nutritional composition made using isolated organic matter |
| 07/14/2011 | US20110171314 Non-viral compositions and methods for transfecting gut cells in vivo |
| 07/14/2011 | US20110171313 Composition containing ultra-micronized palmitoyl-ethanolamide |
| 07/14/2011 | US20110171311 Stable hydrogel compositions including additives |
| 07/14/2011 | US20110171310 Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use |
| 07/14/2011 | US20110171308 Ph-sensitive solid pharmaceutical composition for oral preparation and preparation method thereof |
| 07/14/2011 | US20110171307 Methods and products for treatment of diseases |
| 07/14/2011 | US20110171306 Methods and products for treatment of diseases |
| 07/14/2011 | US20110171305 Dehydrated hydrogel inclusion complex of a bioactive agent with flowable drug delivery system |
| 07/14/2011 | US20110171303 Dosage form containing (s)-pantoprazole as active ingredient |
| 07/14/2011 | US20110171302 Method for treating neurodegenerative disorders with oral dosage formulation containing both immediate-release and sustained-release drugs |
| 07/14/2011 | US20110171301 F, G, H, I and K Crystal Forms of Imatinib Mesylate |
| 07/14/2011 | US20110171300 Delta 9 tetrahydrocannabinol derivatives |
| 07/14/2011 | US20110171299 Doxycycline metal complex in a solid dosage form |
| 07/14/2011 | US20110171297 Sustained release formulation for venlafaxine hydrochloride |
| 07/14/2011 | US20110171296 Method and preparation for binding acetaldehyde in saliva, the stomach and the large intestine |
| 07/14/2011 | US20110171295 Immediate release compositions of acid labile drugs |
| 07/14/2011 | US20110171289 Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis |
| 07/14/2011 | US20110171287 Use of Oligonucleotides with Modified Bases as Antiviral Agents |
| 07/14/2011 | US20110171284 Povidone-iodine and sucrose wound healing dressing |
| 07/14/2011 | US20110171283 Composition containing at least one nutrivite, at least one disinfecting or decontaminating, and/or at least one protease-inhibiting active compound and/or active compound complex |
| 07/14/2011 | US20110171281 Soft capsule composition and method of use |
| 07/14/2011 | US20110171276 Non-Viral Compositions and Methods for Transfecting Gut Cells In Vivo |
| 07/14/2011 | US20110171275 Gastroretentive drug delivery system, preparation method and use thereof |
| 07/14/2011 | US20110171274 Fesoterodine Substantially Free of Dehydroxy Impurity |
| 07/14/2011 | US20110171273 Stable anti-nausea oral spray formulations and methods |
| 07/14/2011 | US20110171272 Urological medical devices for release of prostatically beneficial therapeutic agents |
| 07/14/2011 | US20110171271 Citrate-Based Dialysate Chemical Formulations |
| 07/14/2011 | US20110171270 Novel solid state forms of laquinimod and its sodium salt |
| 07/14/2011 | US20110171269 Method for manufacturing uniform size polymeric nanoparticles containing poorly soluble drugs |
| 07/14/2011 | US20110171264 Protein Formulation |
| 07/14/2011 | US20110171255 Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant |
| 07/14/2011 | US20110171244 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof |
| 07/14/2011 | US20110171240 Use of ccr9, ccl25/teck, and integrin alpha4 in diagnosis and treatment of melanoma metastasis in the small intestine |
| 07/14/2011 | US20110171239 pH INDUCED SILK GELS AND USES THEREOF |
| 07/14/2011 | US20110171238 Novel stra6 polypeptides |
| 07/14/2011 | US20110171233 Antibodies Against Human Cytomegalovirus (HCMV) |
| 07/14/2011 | US20110171232 Methods of treating autoimmune diseases caused by small intestinal bacterial overgrowth |
| 07/14/2011 | US20110171230 Method of Identifying Agents that Promote Axonal Development |
| 07/14/2011 | US20110171228 Methods and Compositions Relating to the Regulation of Apoptosis by MUC1 and BH3-Containing Proapoptotic Proteins |
| 07/14/2011 | US20110171224 PsrP IS A PROTECTIVE ANTIGEN AGAINST PNEUMOCOCCAL INFECTION |
| 07/14/2011 | US20110171221 Compositions and methods for the treatment of a neoplasia |
| 07/14/2011 | US20110171207 Compositions and methods for treating inflammation and auto-immune diseases |
| 07/14/2011 | US20110171205 Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor |
| 07/14/2011 | US20110171203 Methods for treating neoplastic disease targeting o-linked n-acetylglucosamine modifications of cellular protein |
| 07/14/2011 | US20110171195 Methods and compositions for treating urinary tract infections using agents that mimic or elevate cyclic amp |
| 07/14/2011 | US20110171193 Compositions and methods for treating pulmonary hypertension |
| 07/14/2011 | US20110171192 Substituted amine derivative and medicinal composition comprising same as the active ingredient |
| 07/14/2011 | US20110171191 Suppression of neuroendocrine diseases |
| 07/14/2011 | US20110171188 Non-thermal plasma for wound treatment and associated apparatus and method |
| 07/14/2011 | US20110171187 Dietary supplements for promotion of growth, repair, and maintenance of bone and joints |
| 07/14/2011 | US20110171177 Compositions and Methods for Inhibiting Entry of a Hepatic Virus |
| 07/14/2011 | US20110171176 Complement antagonists and uses thereof |